Table 3.

Characteristic of the patients with the presence of LFs with RRS in CD and control group.

LFs with RRS	Number of patients	Follow-up week 8 after start or change of the therapy	The extent of the CD			Duration of disease in months (mean duration and range)	Disease activity based on CDAI score
			ileal	colonic	Ileo-colonic		remission < 150	mild to moderate	severe > 450
CD known	4	2/ aphthous ulcers 2/ mucosal healing	3	-	1	6 (2-20)	-	3	1
CD suspected and histologically confirmed	9	8/aphthous ulcers 1/mucosal healing	7	-	2	8 (4-12)	-	7	4
Control group, histological confirmation of CD	2	1/ aphthous ulcers 1/mucosal healing	2	-	-	2 (1-4)